Skip to main content
OpenTrials

Clinical trial condition

Gastroesophageal Junction Cancer

Explore clinical trials studying Gastroesophageal Junction Cancer. Study availability and eligibility vary by location and protocol.

35 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Gastroesophageal Junction Cancer trial results

Completed

Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)

NCT03221426

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +8 more
Locations
  • City of Hope ( Site 0005) Duarte, California, United States
  • Yale Cancer Center ( Site 0016) New Haven, Connecticut, United States
  • Georgetown University ( Site 0015) Washington D.C., District of Columbia, United States
  • Northwestern University - Robert H. Lurie Comprehensive Cancer Center ( Site 0018) Chicago, Illinois, United States
View all 171 locations
View Trial Details
Completed

Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension

NCT04882241

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +8 more
Locations
  • Afflilated Hospital of Bengbu Medical College-Surgical Oncology (Site 0638) Bengbu, Anhui, China
  • Beijing Friendship Hospital ( Site 0637) Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital ( Site 0221) Beijing, Beijing Municipality, China
  • Fujian Provincial Cancer Hospital ( Site 0230) Fuzhou, Fujian, China
View all 20 locations
View Trial Details
Completed

A Study of Treatment Patterns in HER2-positive Unresectable and Advanced Gastric/ Gastroesophageal Junction Cancer in China

NCT06585501

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • The First Affiliated Hospital of Fujian Medical University Fuzhou, China
  • Zhejiang Provincial People's Hospital Hangzhou, China
  • Harbin Medical University Cancer Hospital Harbin, China
View Trial Details
Completed

Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

NCT02872116

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • Local Institution - 0005 Los Angeles, California, United States
  • Local Institution - 0001 San Francisco, California, United States
  • Local Institution - 0066 Aurora, Colorado, United States
  • Local Institution - 0151 Denver, Colorado, United States
View all 179 locations
View Trial Details
Completed

Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer

NCT04082364

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +8 more
Locations
  • Mayo Clinic - Scottsdale Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center - Duarte Duarte, California, United States
  • Norris Comprehensive Cancer Center (USC) Los Angeles, California, United States
  • Salinas Memorial Salinas, California, United States
View all 73 locations
View Trial Details
Completed

Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without Tislelizumab

NCT04276493

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • The Affiliated Hospital of Military Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
  • Guangdong Provincial Peoples Hospital Huifu Branch Guangzhou, Guangdong, China
View all 21 locations
View Trial Details
Completed

A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer

NCT02178956

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations
  • Mayo Clinic - Arizona Scottsdale, Arizona, United States
  • Colorado Cancer Research Program Denver, Colorado, United States
  • Indiana University Health Goshen Center For Cancer Care Goshen, Indiana, United States
  • Northern Indiana Cancer Research Consortium South Bend, Indiana, United States
View all 263 locations
View Trial Details

Related conditions